NCT06347003Phase 3Active not recruiting

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

Study sponsor: Arrowhead Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-06-12Actual

Enrollment · participants446Actual

Source updated2026-07-15Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-07-15 · 2 fields changed

Completion date type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~Jun 2026~~

+ After

12 Jun 2026

Check registry source